NeuroVive proposes resolution on private placement and rights issue totaling approximately SEK 111 m
On 20 November 2013, the Board of Directors of NeuroVive Pharmaceutical AB (publ), (the "Company") decided to convene an Extraordinary General Meeting (EGM) and to propose that the Meeting approves a ...